BARCLAYS PLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 312069 LONDON, X0

Back to RARE Full portfolio

Position in RARE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,233,455

-$3,026,949 QoQ

Shares Held

249,807

-30.4% QoQ

Ownership

0.254%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Derivatives in RARE

reported options exposure · as of Dec 31, 2025

CallValue

$4,600,000

CallShares

200,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. RARE ranks #39 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

All Filings in RARE

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,233,455	249,807	-30.4%	Shares	Defined	2026-05-15
2025-12-31	$8,260,404	359,148	+79.6%	Shares	Sole	2026-02-13
2025-12-31	$4,600,000	200,000	-53.0%	Call	Sole	2026-02-13
2025-09-30	$12,794,556	425,351	+112.7%	Shares	Sole	2026-03-31
2025-09-30	$6,016,000	200,000	+12.0%	Call	Sole	2026-03-31
2025-06-30	$6,494,295	178,611	-54.4%	Shares	Sole	2026-02-27
2025-06-30	$14,238,576	391,600	+3032.8%	Call	Sole	2026-02-27
2025-03-31	$452,625	12,500	-68.7%	Put	Sole	2026-03-17
2025-03-31	$1,444,779	39,900	-72.1%	Call	Sole	2026-03-17
2025-03-31	$5,173,720	142,881	-30.7%	Shares	Sole	2026-03-17
2024-12-31	$8,670,962	206,108	+159.1%	Shares	Sole	2026-03-19
2024-09-30	$4,418,780	79,546	+26.4%	Shares	Sole	2026-03-31
2024-06-30	$2,585,724	62,913	-63.8%	Shares	Sole	2026-03-23
2024-06-30	$7,151,400	174,000	+480.0%	Call	Sole	2026-03-23
2024-03-31	$1,400,700	30,000	-74.7%	Call	Sole	2026-03-24
2024-03-31	$5,545,510	118,773	+295.9%	Shares	Sole	2026-03-24
2024-03-31	$1,400,700	30,000	0.0%	Put	Sole	2026-03-24
2023-12-31	$1,434,600	30,000	-82.0%	Put	Sole	2026-03-24
2023-12-31	$7,973,602	166,742	+455.8%	Shares	Sole	2026-03-24
2023-12-31	$1,434,600	30,000	-75.1%	Call	Sole	2026-03-24
2023-09-30	$4,302,705	120,693	+18.2%	Shares	Sole	2026-03-26
2023-06-30	$4,711,763	102,141	+11.4%	Shares	Sole	2026-03-27
2023-03-31	$3,675,845	91,667	-26.4%	Shares	Sole	2026-03-30
2022-12-31	$5,772,115	124,587	+7.8%	Shares	Sole	2026-03-30
2022-09-30	$4,786,580	115,590	+475.8%	Shares	Sole	2022-11-03
2022-06-30	$1,197,674	20,075	+2.4%	Shares	Sole	2022-08-12
2022-03-31	$1,423,496	19,602	-16.3%	Shares	Sole	2022-05-16
2021-12-31	$1,970,228	23,430	+396.9%	Shares	Sole	2022-02-23
2021-09-30	$425,245	4,715	-80.7%	Shares	Sole	2021-11-09
2021-06-30	$2,324,631	24,380	-66.0%	Shares	Sole	2021-08-13
2021-03-31	$8,161,028	71,676	+204.7%	Shares	Sole	2021-05-13
2020-12-31	$3,256,426	23,524	-75.9%	Shares	Sole	2021-02-11
2020-09-30	$8,024,290	97,631	+183.2%	Shares	Sole	2020-11-12
2020-06-30	$2,696,242	34,470	-77.3%	Shares	Sole	2020-08-12
2020-03-31	$6,743,229	151,772	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.